In this work we evaluate the effect of polymer composition and architecture of (PEGylated) polyesters on particle size and paclitaxel (PTX) loading for particles manufactured via microfluidic-assisted, continuous-flow nanoprecipitation using two microfluidic chips with different geometries and mixing principles.
Introduction
Nanoprecipitation has gained attention as one of the most simplistic preparative methods for the manufacturing of nanoparticles with the view to designing delivery systems with good drug loadings, controlled drug release, long circulation times, and hence, the ability to increase the therapeutic index of drugs (D'Addio and Prud'homme, 2011; Schubert et al., 2011) . In this preparative process, a solution of a hydrophobic polymer dissolved in a water-miscible organic solvent is streamed into an aqueous solution (non solvent) and, as the solubility of the polymer in the mixture decreases, polymer aggregates form (nucleation) that increase in size via both deposition of further chains and coalescence (growth). Particle growth is halted by the gradual adsorption of a surfactant onto the particle, making it unsuitable for further polymer association; the surfactant is generally present in the water phase, or as an alternative, the polymer itself can have surfactant (amphiphilic) properties resulting in a preferential localisation of the hydrophilic block in the particle surface. Particle properties such as size can be controlled by acting on the polymer's macromolecular parameters (i.e. composition and architecture) and/or on the nanoprecipitation conditions (i.e. solvent/water ratio, solvent/surfactant type, flow rates in flow processes, agitation speed in batch ones). In addition, by using emulsifiers (e.g. Pluronics ®) or amphiphilic polymers (e.g. PEGylation) nanoprecipitation also provides a straight forward method to modulate the composition and density of the hydrophilic surface layer of the particles, which is of key importance to avoid their early opsonisation and uptake by the mononuclear phagocytic system (Gustafson et al., 2015; Owens and Peppas, 2006) .
The pharmaceutical industry has traditionally relied on batch processes (reactor + agitator) for the production of different types of particles (Martínez Rivas et al., 2017; Paliwal et al., 2014) . However, despite being a cost-saving and rather simple manufacturing strategy, batch processes are often affected by fluidodynamic issues (e.g. variable flow rate and Reynolds' number within the vessel), which can give rise to large heterogeneities in the nanoparticles produced in the same batch and to severe practical limitations in terms of process reproducibility and scalability (Ciofalo et al., 1996; Kumaresan and Joshi, 2006) . Currently, attention is gradually being shifted away from batch towards continuous (flow) manufacturing approaches (Lee et al., 2015) . In the case of nanoprecipitation this is particularly advantageous for both heat and mass transfer, and offers an unparalleled stability of the mixing fluidodynamics (geometry and rate of mixing of the two phases), and therefore of the parameters defining the kinetics of phase separation, particle nucleation and growth (Liu et al., 2017b) . Importantly, in microfluidic-assisted nanoprecipitation the mixing performance of the microfluidic chip is heavily influenced by its geometry (mixing junction and mixing channel) and the stream flow rate, as recently studied by Reckamp et al. (2017) on a series of commercially available microreactors operating under different mixing principles (simple contacting, flow obstacles, split and recombine, and multilamination). Hence, although continuous-flow nanoprecipitation has potential to offer superior manufacturing capabilities in scale-up of formulations (Lim et al., 2014) , careful selection of microfluidic chip geometry and flow conditions is key for optimal nanoparticle design.
Since the pioneering work by the group of Benita (Fessi et al., 1989 ) on the nanoprecipitation of poly(lactic-co-glycolic acid) (PLGA) nanocapsules, efforts were initially devoted to develop microfluidic approaches for the preparation of various types of microsystems (Martín-Banderas et al., 2005; Nisisako et al., 2004; Seo et al., 2005; Xu et al., 2005) . The first example of this kind for the preparation of self-assembled poly(ethylene glycol)-bl-poly(lactic-co-glycolic acid) (PEG-PLGA) organic nanoparticles was later published by the group of Farokhzad (Karnik et al., 2008) . Since these first examples, many authors have explored continuous-flow approaches for the manufacturing of Scheme 1. A Sn(Oct) 2 -catalysed ringopening (co)polymerisation (ROP) of lactide (LA) and ε-caprolactone (CL) used to provide all macromolecular structures: a) 1-dodecanol was employed to yield linear, hydrophobic PLxCLy (top structure), b) hydroxyl-terminated PEG to yield linear, amphiphilic PEG-PLxCLy) (middle structure), c) a 4-armer PEG to yield 4-armed star, amphiphilic (PEG) 4 -(PLxCLy) 4 (bottom structure). In the drawing of the right, the polyester and PEG blocks are respectively graphically represented in blue and red. B Schematic representation of the micromixer and cross-flow chips used in this study. Inlet pictures represent a magnification of the mixing junction of each chip. Reproduced with permission from Syrris Ltd. C Main specifications of the micromixer and crossflow chips. Please note that the number of inlets refers to the number of tubing connections of the chip, not to the number of inlet channels at the mixing junction (which is three in both mixers; blue and red arrows). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
nano-and micro-sized delivery systems using different substrates (Gupta et al., 2016; Liu et al., 2017b; Sanjay et al., 2017) . Polyesters, and in particular PLGA, have been undoubtedly the most extensively studied polymer platforms, as recently reviewed by Li and Jiang (2018) with particular emphasis on cancer-related drug delivery therapies. Polyesters owe their extensive use in parenteral drug products, including nanomedicines, to their physicochemical and biological properties, i.e. drug release, biocompatibility and biodegradability, which is illustrated by a variety of PLGA-based drugs receiving FDA approval for the treatment of different types of cancers and other diseases (Reckamp et al., 2017) , while many others are in clinical trials. Polyester properties can be modulated by changing chemical composition e.g. the different polarity and hydrolytic stability of poly(ε-caprolactone) (PCL) and poly(lactic acid) (PLA) (Siparsky et al., 1998) . Polymer architecture can also play a role, and polyester branching has been exploited to confer a number of advantages over more conventional linear structures (d 'Arcy et al., 2016) , including: affording a higher degree of functionality, reduced viscosity at high concentration, different hydrolytic degradation kinetic, and in the case of amphiphilic block copolymers an enhanced stability of micellar self-assembly. For instance, branched structures such as star PLDLA (Yang et al., 2010) and PEG-PLGA star block copolymers (Breitenbach et al., 2000) have shown faster kinetics of degradation and drug release than their linear counterparts.
In a previous work we have reported on microfluidic-assisted nanoprecipitation of PLGA using an X-shaped microreactor chip for the encapsulation of the anticancer drug paclitaxel (PTX) (Donno et al., 2017) . Herein, we seek to further expand our study of the continuousflow preparation of polyester particles, with particular emphasis on the impact of both macromolecular and microfluidic parameters on nanoparticle properties such as lower particle size (to achieve a preferential accumulation of particles in solid tumours (Perrault et al., 2009) ) and higher drug loading efficiency to enable patient convenience, minimise excipient load to patients and reduce the cost of goods.
Specifically, we have replaced PLGA with more hydrophobic polyesters, namely poly(D,L-lactic acid-co-caprolactone) (PLCL) with variable LA/CL ratio, which were also synthesized as amphiphilic block copolymers using PEG as the macroinitiator, both in linear and 4-armed star architectures, yielding linear PL x CL y , linear PEG-PL x CL y and 4-arm, star (PEG) 4 -(PL x CL y ) 4 copolymers as shown in Scheme 1A. From the microfluidic setup perspective, we have employed two commercially available microfluidic chips from Syrris Ltd (https://syrris.com/): a cross-flow chip and a micromixer chip, both of which have distinct channel and mixing junction geometries, and thus operate under different mixing principles (Scheme 1B and C). In summary, the cross-flow chip displays an X-shaped mixing junction that favours 2D flow focusing and a mixing channel that operates under a flow obstacle mixing principle, whereas the micromixer presents a Y-shaped mixing junction and a split and recombine path (serpentine) that combines 2D flow focusing and a split and recombine mixing mechanism. To the best of our knowledge this is the first example of continuous-flow nanoprecipitation using a micromixer chip with the above characteristics, whereas cross-shaped chips have been rather extensively used for nanoprecipitation of polymeric particles (Donno et al., 2017; Liu et al., 2017b; Sanjay et al., 2017) .
Materials & methods

Materials
ROP initiators (solids) used in this work were first finely ground with the aid of a mortar and then dried under vacuum (0.1 mbar) at 60°C for 48 h in the presence of anhydrous phosphorus pentoxide (P 4 O 10 ) prior to polymerization. 4-Armed, star PEG-OH 20KDa (Jemkem Technology, USA) was purchased as a raw material and purified in-house before use: first, the polymer was dissolved in water and sequentially washed with diethyl ether and ethyl acetate. The aqueous layer was saturated with NaCl and the 4-armed PEG-OH was extracted with dichloromethane. The organic layer was dried over MgSO 4 and concentrated under vacuum, and the resulting solid ground and finally dried in a vacuum oven as described above. MeO-PEG-OH 5KDa, 3,6-dimethyl-1,4-dioxane-2,5-dione aka rac-lactide (> 99%), 1-dodecanol, 2-hydroxypropyl-β-cyclodextrin (HPCD) and Pluronic F127 were purchased from SigmaAldrich (Gillingham, UK). Stannous 2-ethylhexanote (96%) was purchased from AlfaAesar (Heysham, UK) and used as received. ε-Caprolactone (> 99%) was obtained from Fisher Scientific (Loughborough, UK) and dried over activated 4 Å molecular sieves for 48 h before use. Paclitaxel (PTX) was purchased from Apollo Scientific (Manchester, UK) and kept at −20°C for longterm storage. CDCl 3 was purchased from VWR (Lutterworth, UK). Ultrafiltration discs of molecular weight cut-off (MWCO) 100 kDa were purchased from Millipore (Watford, UK). All solvents were of analytical grade and purchased from Fisher Scientific (Loughborough, UK). Ultrapure (type 1) water was obtained from a Synergy UV instrument (Millipore, UK). All polymerizations and related preparative operations were performed under dry and inert conditions (O 2 and H 2 O both < 10 ppm) inside an IL-2GB glove box (Innovative Technologies, USA).
Physico-chemical characterization
Nuclear Magnetic Resonance (NMR):
1 H NMR spectra were recorded on 1.0% wt polymer solutions in CDCl 3 using a Bruker Avance 400 MHz spectrometer. ACD/NMR processor (ACD/labs, UK) was used for spectral processing. The LA/CL mol ratio was calculated from the integration of the resonances of the methine group of LA units (4.91-5.45 ppm, A proton) and the methylene group in epsilon position to the ester group of CL units (4.00-4.19 ppm, G protons). Assignment of NMR resonances of selected polymers is shown in Fig. 1A . Dynamic Light Scattering (DLS): Hydrodynamic diameter (Z-average size) and particle size polydispersity (PDI) of (non-loaded) particles as prepared were measured at 25°C (pre-equilibration for 2 min; 1 mg/ mL) using a Zetasizer Nano ZS (Model ZEN3600, Malvern Instruments Ltd., UK) equipped with a solid state HeNe laser (λ = 633 nm) at a scattering angle of 173°. Size values are presented as the average of the Z-average size measurements of three independent samples. Particle size distributions were calculated by applying the General-Purpose algorithm.
Fourier-Transform Infra-Red (FTIR): FTIR spectra were recorded in ATR mode on a Tensor 27 Bruker spectrometer (Bruker UK Limited, UK) equipped with a 3000 Series TM High Stability Temperature Controller with RS232 Control (Specac, UK). For each experiment, approximately 10 mg of solid substrate were placed on the Golden Gate Heated Diamond ATR top plate of the instrument. Spectra were recorded at room temperature.
Gel Permeation Chromatography (GPC): Molecular weights were determined using an OMNISEC system (Malvern Instruments Ltd, UK) equipped with high sensitivity refractive index (RI) and right angle/low angle light scattering (RALS/LALS) detectors and 2 × Viscotek T3000 6 µm particle size 300 × 7.8 mm maximum 500 Å pore size columns (Malvern Instruments). Mobile phase was tetrahydrofuran (THF) using a flow rate of 1 mL/min and 100 µL samples were injected from a solution of THF with 25% dimethylacetamide at approximately 5 mg/mL. The detectors were calibrated using a poly(ethylene glycol) 24 kDa standard (Malvern Instruments Ltd). Refractive index increments (dn/ dc) were calculated within the measurement by determining the RI area for each sample and using accurate solution concentrations. Due to the small size and therefore isotropic scattering of the polymers only the right-angle light scattering (RALS) detector was used to calculate molecular weight distributions.
Asymmetric Flow Field-Flow Fractionation (AF4): An AF2000 TM AF4 system (Postnova Analytics, Germany) was coupled to a UV/VIS spectrophotometer (220/280 nm; Shimadzu SPD-20A, Postnova Analytics, UK), MALS (Viscotek SEC-MALS20; Malvern Instruments Ltc, UK), refractive index (Optilab T-rEX; Wyatt Technology, Germany) detectors in the given order. The AF4 channel was equipped with a 350 μm spacer, and a 10 kDa MWCO membrane of regenerated cellulose as the accumulation wall. A 0.02% wt NaN3 solution filtered through a 0.1 μm was used as eluent. In a typical experiment, the detector flow rate was set at 0.5 mL/min and 100 μL of samples were injected over 5 min at 0.2 mL/min with a cross flow of 1.0 mL/min and a focusing flow of 1.3 mL/min (focusing step). For the elution step, the cross flow was maintained constant at 1.0 mL/min for 5 min and then exponentially (exponent = 0.40) decreased to 0.1 mL/min over 40 min and subsequently kept at 0.1 mL/min for an additional 5 min, followed by a 2 min rinse step (i.e. cross flow at 0 mL/min and purge valve on). The AF4 data was fitted with a sphere model to obtain radius of gyration distributions.
Polymer synthesis
Ring-opening polymerization (ROP) experiments were carried out in bulk at 140°C following a procedure reported by Sarasua's group (Fernández et al., 2012) for the synthesis of homopolymers and statistical copolymers (of LA and CL). Briefly, adequate amounts of 3,6-dimethyl-1,4-dioxane-2,5-dione and CL (ca. 7.5 g combined weight) and the alcohol initiators (1-dodecanol, MeO-PEG-OH and 4-armed MeO-PEG-OH) were introduced into the reaction vessels of a Carrousel 12 parallel reactor (Radleys, UK) placed inside a glove box (O 2 and H 2 O both < 10 ppm). Reagents were pre-heated at 140°C and then stannous 2-ethylhexanote (1:2 initiator-to-catalyst mol ratio) was added to the reaction vessel to initiate the polymerisation. The reaction was stirred at that temperature for 24 h. Finally, the reaction mixture was allowed to cool down, dissolved in dichloromethane and precipitated in methanol (three times) and then in a mixture of hexane:diethyl ether 1:1 v/v (three times). Finally, the polymers were dried under vacuum at 50°C for 24 h, and stored at −20°C until use. Yield: 67-80% for polyesters, 72-87% for PEGylated polyesters.
Note: polyesters with a low polydispersity can be prepared in highly stringent dry conditions requiring the purification of commercial reagents: crystallisation/sublimation for LA; high vacuum distillation for CL, stannous 2-ethylhexanote and 1-dodecanol; and azeotropic distillation of PEG solution in toluene. Here, we have opted for a more simplistic approach for the elimination of water traces in commercial reagents: liquids were dried with activated 4 Å molecular sieves (room temperature, 48 h) and solids were heated under vacuum (0.1 mbar, 60°C, 48 h, in presence of P 4 O 10 ). (Fig. 1A) 4 showed very similar FTIR fingerprints, although small shifts of ca. 10-20 cm −1 could be observed for some of them (Fig. 1B) .
Microfluidic-assisted nanoprecipitation
The automated Asia 320 microfluidic system (Syrris Ltd, Royston, UK) was used for all preparations. Nanoprecipitation was performed from a polyester solution in acetone and a water solution containing either 0.015% wt Pluronic F127 surfactant (for polyesters) or no surfactant (PEGylated polyesters) using either an X-shaped (1000 μL, 3-input) reaction chip (labelled as "cross-flow") or a Y-shaped (26 μL, 2 input) reaction chip (labelled as "micromixer") following similar nanoprecipitation conditions as previously reported by us (Donno et al., 2017) . For comparative purposes, and unless otherwise stated, the same nanoprecipitation conditions (i.e. total flow rate, flow rate ratio, and temperature) were applied with both microfluidic chips, while polymer concentration was varied to fine tune nanoparticle size (i.e. to target less than 130 nm). Briefly, the polyester concentration in the organic phase was chosen to yield nanoparticle solutions with 0.83, 0.50 or 0.25 mg/mL polyester content after mixing. The temperature of the chip was set at 25°C. For drug-loaded particles, the acetone solution contained PTX at a concentration suitable to obtain a 12.5 or 5% wt in comparison to the polymer content. The individual flow rates of each channel were selected to have an acetone/water flow rate ratio of 0.2 and a total flow of 2 mL/min for all experiments. Finally, acetone was allowed to evaporate overnight at room temperature, and MilliQ water was then added in amounts equal to the volume of liquid lost, in order to maintain the initial nanoparticle concentration. For drug-loaded particles, a filtration step was performed with 0.22 μm PES filters (Millipore, UK) in order to filter out non-encapsulated drug present in suspension as needle-like crystals.
Drug loading and encapsulation efficiency
PTX loading and encapsulation efficiency were calculated before ("as prepared/filtered") and after removal of non-encapsulated drug ("washed"). It is important to note that we refer to non-encapsulated drug as the combination of drug in solution and drug loosely adsorbed onto the nanoparticle surface (equivalent to the "burst" release of PTX at 4°C after 30 min). Drug encapsulation of nanoparticles (as prepared, filtered) was measured by HPLC after mixing 100 μL of the drug-loaded particles with an equal volume of acetone. For HPLC analysis, an Agilent 1100 Series HPLC equipped with a Zorbax Eclipse XDB-C18 column (4.5 × 150 mm; 5 μm bead diameter) and an UV detector (UV 1575, Jasco) were used to quantify the drug content. Samples were eluted with acetonitrile:water mixtures using a single linear gradient from 30:70 to 70:30 v/v acetonitrile:water mixture in 20 min (retention time = 14.5 min). Elution flow rate, injection volume and detection wavelength were set at 1.0 mL/min, 15 μL and 260 nm, respectively. The drug loading (%) was expressed as the mass of drug loaded over the total weighted mass of the freeze dried samples (×100). The encapsulation efficiency (%) was expressed as the amount of drug encapsulated over total drug added (×100).
"Washing" procedure: Non-encapsulated drug was separated through a procedure based on the ultrafiltration (MWCO 100KDa) of a 1:1:1 v/v/v mixture of nanoparticle dispersion (after 0.22 μm filtration), water, and 30% wt HPCD in water (so as to reach > 3 times sink for any given formulation). Separation of soluble PTX in the HPCD solution from the nanoparticles in suspension was performed by ultrafiltration after an incubation period of 30 min at 4°C under moderate stirring. Nanoparticle solutions were ultrafiltered to about half of the initial volume. The amount of encapsulated PTX after the washing step was estimated after subtracting the amount of HPCD:PTX complex in the ultrafiltrate as calculated by HPLC using the same instrumental conditions as described above.
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Synthesis of linear and 4-armed (PEGylated) (co)polymers
Polyesters were prepared from ring-opening polymerization (ROP) of 3,6-dimethyl-1,4-dioxane-2,5-dione (LA) and ε-caprolactone (CL) in bulk using stannous 2-ethylhexanote as catalyst and at 140°C, a temperature that was chosen to ensure a good incorporation of the much less reactive CL monomer into the polymer chain; as reported by the group of Sarasua (Fernández et al., 2012) , the preparation of linear LA/ CL copolymers at lower temperatures results in polymers with a decreased incorporation of CL monomer and with a lower statistical character, whereas higher temperatures hamper the efficiency of the catalyst. Also, a rather low initiator-to-catalyst molar ratio of 1:2 was used in order to minimise the presence of metal impurities in the final polymers. Using such polymerization conditions, here we varied two macromolecular parameters: first, the monomer composition with the preparation of polyester blocks with different LA/CL ratios (CL mol % in the monomer feed of 0, 12.5 and 25); second, we varied the polymer architecture (polyester vs PEGylated polyester and linear vs 4-armed star) by performing ROP from different alcohol-terminated initiators (Scheme 1): a) 1-dodecanol, produced linear PL x CL y , b) a methoxyterminated PEG rendered linear block copolymer PEG-PL x CL y , and c) a 4-armed PEG was used to prepare star-shaped block copolymer (PEG) 4 -(PL x CL y ) 4 . It is worth pointing out that, due to the use of an "arm-first" (as opposed to a "core first") approach to the synthesis of (PEG) 4 -(PL x CL y ) 4 , this copolymer is composed of a central hydrophilic PEG block from which four hydrophobic polyester arms branch out.
A number of techniques were used for the physicochemical characterisation of this library of polyesters ( Fig. 1A (Fig. 1A) . It is also worth mentioning that the calculated LA/ CL ratios for all polymers were close to their feed monomer compositions (Table 1) . b) FTIR showed minute differences in band wavelength and intensity among all polymers, probably the sole exception being the increase of the intensity of the v s CH 2 band at ca. 2870 cm −1 for polyesters with a higher CL content (more CH 2 groups) within each polymer family; however, this increase in intensity is always small, and far less evident for PEGylated structures, for which the contribution of the PEG block to this IR band is already significant in polymers lacking CL (Fig. 1B) . c) GPC revealed an increase of molecular weight of the polymers from PL x CL y to PEG-PL x CL y as expected from the incorporation of larger (macromolecular) initiators (Table 1) . However, the actual size of the polyester blocks decreased, in particular for the star macromolecules; this is possibly due to initiation from water molecules present in the initiators (water content: 1-dodecanol > linear PEG > 4-armed PEG) leading to shorter chains, which would explain the presence of a secondary, low molecular weight GPC peak in (PEG) 4 -(PL x CL y ) 4 as shown in Fig. 1C . In addition, this side reaction also negatively impacted on the dispersity of the polymers (Table 1) , although rather broad molecular weight distributions have also been reported for PLCL prepared under similar polymerisation conditions (Fernández et al., 2012) .
Microfluidic-assisted nanoprecipitation
With regards to mixing of fluid streams, the main driver for mixing at low flow rates is molecular diffusion whereas turbulence mixing may start to occur at much larger flows (i.e. Reynolds (Re) numbers ≈2000). In order to achieve turbulence mixing in microscale mixers a design that favours the formation of turbulent effects is typically required (Lim et al., 2014; Liu et al., 2017a). However, it is worth mentioning that in passive micromixers with bent and curved channels the of LA and CL monomers (uppercase letters) and the different initiators (lowercase letters). Please note that splitting of some of the CL resonances (i.e. G and C) occurs due to copolymerization and corresponds to the CL-CL dyad (ca. 2.30 and 4.05 ppm) and the CL-LA dyad (ca. 2.35 and 4.10 ppm) (Fernández et al., 2012) . B FTIR spectra of representative polymers and assignment of characteristic bands (please refer to Materials and Methods for a more comprehensive band assignment). The intensity of all spectra was normalized against the intensity of the ν C]O band at ca. 1725 cm −1
. C Molecular weight distributions from GPC-RI/RALS of representative polymers showing increasing molecular weight for PL x CL y > PEG-PL x CL y > (PEG) 4 -(PL x CL y ) 4 .
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mixing of phases might be affected by chaotic advection and other secondary mixing effects like vortices and Dean flows that start to occur much earlier than Re numbers indicate transition or turbulent flow regimes (Dreher et al., 2009; Feng et al., 2015; Hermann et al., 2018; Kockmann et al., 2005) . In this case, therefore, mixing may not be ascribed solely to a molecular diffusion-dominated process but it could also be affected by such secondary mixing effects. In this work, two commercially available microfluidic chips from Syrris Ltd were used: a cross-shaped (also known as double T-shaped) microreactor and a Y-shaped micromixer. The two microfluidic chips not only differ in their geometry at the mixing junction but also present other unique structural features which define their operating mixing principle and the mixing kinetics of the two phases (Scheme 1):
Cross-shaped chip. Its 90°junction angle allows for a 2D laminar flow focusing which results in a more efficient lateral mixing of two phases. Using the approximation of Karnik et al. (2008) for the calculation of mixing times in a similar cross-shaped mixer (
R 2 , where D ≈ 10 −9 m 2 /s is the diffusivity of water, w = 161 μm is the internal diameter of the channel in our system and R = 0.2 is the organic/aqueous flow rate ratio), we could calculate a mixing time of 109 ms under the nanoprecipitation conditions used in this study. However, it is important to note that this approximation was developed for hydrodynamic flow focusing using a two-dimensional model that assumes a negligible contribution of the total flow rate, which on the contrary is a critical parameter affecting the mixing times of conventional microfluidic mixers (Reckamp et al., 2017) . Micromixer. It also allows for a 2D laminar flow focusing due to its Y-shaped junction geometry. However, the most important structural feature of this mixer is a channel path with intersecting channels associated to a split and recombine mixing mechanism, which allows repeated lamination of the stream jets, and hence, the increase of their contact area and consequent reduction of the diffusion length. The unique mixing mechanism of the micromixer further reduces the mixing times of the two phases as compared to the cross-flow chip under comparable nanoprecipitation conditions: mixing times of 5 (Reckamp et al., 2017) and 32 ms (Sanjay et al., 2017) have been experimentally determined at a total flow rated of 2.0 mL/min (although under slightly different mixing conditions).
For comparative purposes, we have kept both the flow rate ratio (0.2) and surfactant concentration (0.015% wt solution of Pluronic F127) constant for all the microfluidic experiments, as optimized in our previous paper (Donno et al., 2017) , and varied the nature and the concentration of the polymer. Intensity-based Z-average hydrodynamic diameters and polydispersity values of nanoparticle formulations prepared at different concentrations are shown in Table 1 ; we have also included colour-coded cells for an easier appreciation of the size differences among the different particle formulations and chips. Nanoparticle size distributions in solution (hydrodynamic size by DLS and radius of gyration (Rg) by AF4/MALLS) of selected formulations are presented in Figs. 2 and 3. TEM and AFM images are also included in the Supporting Information (Fig. SI1) .
The type of microfluidic chip, as well as the nature and concentration of the polymer, had a large influence on particle size. In summary:
Microfluidic chip: With a couple of exceptions, for the same polymer and nanoprecipitation conditions, the cross-flow chip produced particles with Z-average sizes in the range 30-80 nm larger than the micromixer. The slower mixing in the cross-flow chip probably significantly retards the phase segregation (of the amphiphilic polymers) or the surface coating by the surfactant, and thus the surface presentation of hydrophilic groups (from the surfactant or the PEGylated polymers themselves) on the polymer aggregates, while it does not affect the overall phase separation of the polymer from solution. In addition, the micromixer appeared to produce particles with a higher polydispersity than the cross shaped chip (0.15-0.30 vs. 0.05-0.15). On one hand, this is at least partially due to instrumental reasons (larger interference of high scatters on the smaller, isotropic scattering particles by DLS), and on the other hand, it is of a relatively low practical importance since the differences in dispersity are reduced after filtration through 0.22 μm (results not shown).
Polymer type: Independently of the chip type, sizes of PL x CL y particles stabilised with Pluronic F127 are significantly larger than their PEGylated counterparts (Table 2 ). The gap in average size is more pronounced in particles manufactured with the micromixer chip: PEGylated block polyester form particles in the range of 30-50 nm, whereas polyesters are in the range of 85-120 nm. In the case of the particles fabricated with the cross flow-chip, this size difference is reduced with sizes of 80-135 nm for amphiphilic polyester particles, and 110-160 nm for Pluronic F127-coated particles. It is interesting to note that the 4-armed star PEGylated polyesters also produced comparatively smaller particles that their linear counterparts for both chips, although this difference in size can be deemed small (ca. 10 nm). Similar trends were obtained for the radius of gyration (Rg) distributions obtained by asymmetric flow field-flow fractionation (A4F) as shown in Fig. 3 for selected formulations. Overall, the above is a result of the H NMR by using the ratio of the integrations of the resonances corresponding to methine group of LA units (5.02-5.30, protons B in Fig. 1A ) and the methylene group in epsilon position to the ester group of CL units (4.00-4.19 ppm, G protons in Fig. 1A) .
b Weight-average molecular weight ( − M w ) and dispersity index (Ð) determined by GPC measurements with RALS and RI detectors as described in Materials and Methods. Fig. 2 . Representative intensity-based size distributions (by DLS) of nanoparticles prepared with micromixer and cross-flow microfluidic chips. All nanoparticle formulations were prepared with a final concentration of 0.83 mg/ mL.
higher solubility in water and the self-assembly properties of the amphiphilic polymers compared to hydrophobic polyesters (and emulsifier), which have a higher tendency to aggregate at equal mixing times and solvent/water ratios. This effect (solubility and self-assembly in water) is more significant for the star block copolymers that are more prone to self-assemblies with possibly the lowest aggregation number of all the polymer families (Jin et al., 2018) .
Finally, with regards to the LA/CL ratio of the polymer we could not observe a clear effect of this parameter on particle size; although some polymers showed an increase of size with an increase of LA content (e.g. PEG-PL x CL y with the cross-flow chip), the majority of the polymer families showed either relatively small particle size differences or a seemingly random behaviour.
Polymer concentration: Larger particles were generally obtained at higher polymer concentrations for formulations (same polymer family) prepared with both microfluidic chips, although this trend was more noticeable across formulations prepared with the cross-flow chip (Table 2) . Interestingly, polymer concentration seemed to play a lesser determining factor for PEGylated structures, where either small differences or seemingly random (although small) size variations were observed with both chips. This behaviour could be ascribed to the lower aggregation degree of amphiphilic PEGylated polyesters (leading to smaller size variations than among polyester particles), and also in part to the higher polydispersity of particles fabricated with the micromixer, that further hampers the establishment of a clear size-concentration relationship. Nevertheless, a steeper increase in polymer concentration is expected to yield much larger particles eventually leading to macroscopic precipitation, as already seen for PLGA particles (Donno et al., 2017) .
Drug encapsulation
PTX loading experiments were initially attempted using nanoprecipitation conditions leading to particles with average sizes in the range of 30-130 nm, as this is a crucial parameter to a preferential accumulation of particles in solid tumours due to the well-known EPR effect (Perrault et al., 2009) . Hence, for comparative purposes, all formulations fabricated with the cross-flow chip were initially prepared at a polymer concentration of 0.25 mg/mL and all formulations fabricated with the micromixer at 0.83 mg/mL. Also, the feasibility of a PXT target loading of 12.5% wt was assessed first. In addition, it is important to note that prior to any quantification of drug loading the needle-like PTX aggregates generated in solution (i.e. from non-encapsulated drug) were removed via filtration through 0.22 μm pore size filters (formulations labelled as "as prepared, filtered" in Fig. 4) .
Interestingly, and similarly to PLGA nanoparticles (Donno et al., 2017) , relatively low drug loadings were achieved under any condition and significantly below the theoretical loading of 12.5% wt (Fig. 4 ; left column); this indicated a low control over the encapsulation process under these experimental conditions and low encapsulation efficiency, and was ascribed to a thermodynamically-driven drug aggregation in solution as opposed to a kinetically-controlled encapsulation of the drug within the hydrophobic polyester matrix. This was first evidenced by eye with the formation of needle-like crystals in all formulations just a few minutes after the mixing of the two phases. Nevertheless, a number of interesting points could be highlighted from this experiment: a) Cross-flow precipitation of (non-PEGylated) polyesters resulted in a nearly null encapsulation (< 1%), as previously reported for PLGA particles (Donno et al., 2017) . b) PEG-PL x CL y particles prepared with cross-flow chip led to moderate amounts of PTX encapsulation (ca. 3-4% wt loading). c) Micromixer precipitations led to rather poor loadings of < 1% wt in all but one polymer, namely, PL 75 CL 25 , with a 2.6% wt PTX loading.
PTX encapsulation was next attempted at a 5% wt target loading in order to have a better control over the encapsulation process by reducing the thermodynamic driving force for drug re-crystallisation, i.e. supersaturation ( Fig. 4; middle column) . Due to the lower target loading, nanoprecipitation conditions were performed at higher polymer concentrations (0.83 mg/mL with both chips), but we still focused our efforts on particle formulations within our target size (< 130 nm); hence, polyester nanoparticles were excluded from this study as they systematically failed to produce particles of the desired size at such concentration (Table 2) . Interestingly, both cross-flow and micromixer chips showed a general increase in drug loading, which was paralleled by the presence of a comparatively lower amount of PTX crystals in solution (by eye), than for previous loading attempts at a higher drug concentration. The increase in drug loading was equally noticeable with both linear and star polymers, although in both chips the 4-armed star PEGylated polyester family was markedly superior, with a near-quantitative encapsulation efficiency in the majority of the formulations. It is also noticeable that, although there was no clear trend between drug loading and CL content in the polymer within each polymer family, near-quantitative loadings (> 4.5% wt) were typically recorded for CL-rich polymers, which may be ascribed to the high solubility of PTX in a CL rich polyester matrix (Zhang et al., 2011) .
To assess the effectiveness of the incorporation of the drug within the particle polyester matrix we quantified the PTX loading after incubation of particle formulations with 2-hydroxypropyl-β-cyclodextrin (Agüeros et al., 2009 ) and washing by ultrafiltration (formulations labelled as "after washing" in Fig. 4 ; right column). This process is expected to disregard the contribution of any drug not encapsulated in the particle core by eliminating PTX loosely adsorbed onto the nanoparticle surface as well as solubilised drug (ca. 0.3 μg/mL in water).
As expected, this process resulted in a systematic reduction of the nanoparticle PTX loading in all formulations. Importantly: Table 2 Hydrodynamic sizes and polydispersity (PDI) of particles prepared by continuous-flow nanoprecipitation a using two microfluidic chips.
a Nanoprecipitation conditions: total flow rate of 2.0 mg/mL, 25°C, organic/aqueous flow rate ratio 0.2. Please note that the polymer concentration refers to the theoretical polymer content in the final nanoparticle formulations. For nanoprecipitation experiment with (non-PEGylated) PLxCLy, the aqueous phase was composed of a 0.015% wt of Pluronic F127. For nanoprecipitation experiments with PEGylated polymers the aqueous phase was pure water. Values are the average of three independent replicates (typical standard deviation of ca. 5-10 nm in all nanoparticle formulations). Please realize that the black-grey scales represent different size ranges for each microfluidic chip.
a) The drug loss was near-quantitative for PL x CL y particles, independently of the chip used for their preparation, which is not surprising due to the initially low PTX loading in these formulations. b) Particles prepared from PEG-PL x CL y also suffered a steep loss of PTX after washing, above all for the smaller particles produced with the micromixer than for the larger counterpart particles fabricated with the cross-flow chip (Fig. 2) . This quick release of drug in solution could be ascribed to their larger surface-to-volume ratio (proportionally more drug is adsorbed on the particle surface). Importantly, the choice of drug also influences its release from the nanoparticles. As shown by Zhu (2014) with drug-loaded PLGA-PEG particles prepared by flash nanoprecipitation, Ostwald ripening effects initiated by the dissolution of the smaller drug particles were more prominent with drugs of logP values between 2 and 9. However, this effect is possibly much less pronounced here due to the lower drug loading, temperature and shorter incubation times. c) (PEG) 4 -(PL x CL y ) 4 produced particles with the highest PTX content of all formulations, although cross-flow PEG-PL x CL y particles presented a similar PTX content than their (PEG) 4 -(PL x CL y ) 4 counterparts. d) PEGylated polyesters with the highest CL content showed the highest PTX loadings, with the best performing polymer being (PEG) 4 -(PL 75 CL 25 ) 4 with ca. 3.4 and 1.8% wt for cross-flow and micromixer fabricated particles, respectively.
The above drug loadings compare well with previous works of polyesters-based nanoparticles prepared via microfluidic-assisted nanoprecipitation methods (albeit using chips of different geometries than ours); for instance, 0.8-4.8% PTX loadings have been reported for PCL-PEG nanoparticles (Bains et al., 2017) and up to 4.1% for PLA-PEG nanoparticles (Karnik et al., 2008) . As reference, PTX is being currently used in clinical settings to tackle various cancer types with treatments consisting of multiple cycles of 60-200 mg/m 2 PTX doses over up to 24 h infusion periods (Crown et al., 2004) .
Conclusions
We have evaluated the effect of chemical composition and macromolecular architecture of (PEGylated and non-PEGylated) polyesters on the loading of the anticancer drug paclitaxel (PTX) in particles manufactured via microfluidic-assisted flow nanoprecipitation. From a polymer point of view, we have tested a range of polyesters of varying monomer composition (LA/CL ratio) and block architecture (polyester vs PEGylated polyester; linear vs 4-armed star). From an instrumental point of view, we have employed two commercially available microfluidic chips with distinct geometries: a cross-flow chip with an Xshaped mixing junction and a micromixer chip with a Y-shaped mixing junction and a serpentine channel path (faster mixing times). Nanoparticles were produced with average sizes in the range of 30-160 nm: in general, the micromixer chip systematically rendered smaller particles (30-50 nm), and regardless of chip type, smaller sizes were achieved using the PEGylated polyesters. Nanoprecipitation conditions leading to (non-loaded) particles of average sizes < 130 nm were used to assess the loading of paclitaxel (PTX). Under our experimental conditions, higher drug loadings were obtained with PEGylated polyesters, with 4-armed star block copolymers being generally superior across the conditions studies, whereas the cross-flow chip outperformed the micromixer. Finally, decreasing the LA/CL ratio seemed to increase the PTX loading.
Despite the amount of encapsulated PTX achieved by current nanoprecipitation methods still falls below of that achieved by other nanomanufacturing techniques (e.g. nanoemulsion-solvent removal (Hrkach et al., 2012) ), the approach of altering the polymer architecture in combination with the right choice of nanoprecipitation tools for improving drug loading and particle size has been demonstrated in this work. Hence, optimised polymer composition/structures have the potential to enable continuous-flow manufacturing of particles using minimal levels of processing aids, thus simplifying and streamlining downstream clean-up and producing particles with enhanced properties. Fig. 4 . PTX loading (% wt) of particles prepared using a micromixer (top row) and cross-flow (bottom row) microfluidic chips. Nanoparticles labelled "as prepared" refer to filtered samples, whereas samples labelled as "after washing" refer to samples after filtration and ultrafiltration washing (in HPCD 10% wt solution, 30 min, 4°C). n.d. = not determined. Please note that the concentration in parenthesis refers to the theoretical polymer content in the final nanoparticle formulations.
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